Bank of America has a strong reputation for keeping finger on the pulse of the financial world – and one of its key …
Is a pause to the stock market’s continued surge finally in the cards? The talk has turned to rising interest rates and the …
The new coronavirus mutant strains are playing havoc with the already approved Covid-19 vaccines. The latest data shows AstraZeneca’s (AZN) vaccine, AZD1222 is …
Let’s talk about risk and the big picture. It’s an appropriate time, as the big risk – presented by the COVID-19 pandemic – …
At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bottom now, and to no one’s surprise, …
Well, it’s official. Joe Biden is now President, and he’ll be backed – at least for the short term – by Democratic majorities …
Whether markets move up or down, every investor loves a bargain. There’s a thrill in finding a valuable stock at low, low price …
From a company barely known outside industry circles a year ago, Moderna (MRNA) has now become a household name. Forever destined be known …
Risk and reward often travel hand-in-hand, making the stock market both lucrative and dangerous. Among the best exemplars of this axiom are the …
Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. Last Friday, Applied DNA Sciences (APDN) played by the …
